Patent Application
Provisional
App. No. 63/344,917
· Confirmation No. 3217
BIOHAVEN PROVIDES UPDATE ON PHASE 3 CLINICAL TRIAL EVALUATING TRORILUZOLE FOR SPINOCEREBELLAR ATAXIA (SCA)
Applicant:
Biohaven Therapeutics Ltd.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2022-09-29 | C.AD |
Change of Address | 2 | View | |
| 2022-09-29 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-06-02 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-05-23 | ADS |
Application Data Sheet | 8 | View | |
| 2022-05-23 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-05-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2022-05-23 | SPEC |
Specification | 127 | View |
Inventors
Vladimir CORIC
Madison, CT
Melissa BEINER
Madison, CT
Irfan QURESHI
Hackensack, NJ
Gilbert L'Italien
Deep River, CT
Attorneys & Agents of Record
Prosecution
- Customer No.
- 189784
- Docket No.
- 20226-PROV
- Confirmation No.
- 3217
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/344,917
- Filed
- 2022-05-23
External Links